Building valuable artificial intelligence models requires gathering good quality data for every population and data validation, says Luis Ahumada, director of health data science and analytics at Johns Hopkins All Children's Hospital.

Education is a key component, but not the only one, of ensuring safe and explainable AI, says Jeremy Petch, director of digital health innovation at Hamilton Health Sciences.

Ionian Healthcare Consulting founder and consultant Matt Cybulsky relays how providers and payers can use AI and machine learning in value-based care and preventative care to forecast the onset of health conditions and alter patient behavior.

Albert Marinez, Cleveland Clinic’s chief analytics officer, describes the health system’s use of AI, including piloting tools to ease workflow, like ambient listening during patient exams, and lessons learned during early-stage implementation.

Brian Esterly, CEO of TimeDoc Health, discusses key social determinants of health issues, the rise in comorbidities complicating the delivery of care, healthcare deserts, and how health IT can serve as a bridge to all of these patients.

Chris Larkin, chief technology officer at Concord Technologies, talks about how AI tools can improve patient-provider relationships by summarizing records and taking notes so clinicians can focus on directly caring for patients.

Severence MacLaughlin, CEO and founder of DeLorean AI, discusses the merits of buying versus building AI solutions and building a strategy to drive better patient outcomes by leveraging AI.

AI has shaken the industry, but it’s hard to understand how patient data is being collected and used, says Sara Shanti, a partner in Sheppard Mullin’s Corporate Practice Group in Chicago.

Beverly Bell, senior partner, healthcare at Kyndryl, and Steve Fu, principal architect at Amazon Web Services (AWS), talk about healthcare use cases for AI that drive productivity, streamline workflows and deliver care more efficiently.

Precision medicine moved beyond chronic care into long-term care – preventing falls and reducing polypharmacy lists – while precision oncology advancements and broader payment will drive further adoption, says Dr. Joel Diamond, CMO of Aranscia.

Utilization has dropped to 5.4% of medical claims since telehealth use skyrocketed during the pandemic, says Steven Ullman, director at the Center for Health Management and Policy at the University of Miami.

Naomi Fried, founder and CEO of PharmStars, discusses the organization's 5th cohort, which is titled "Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface," and the 11 startups graduated from the accelerator program.